Elaborate has filed a notice of an exempt offering of securities to raise $10,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Elaborate is raising $10,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Nicole Bocskocsky played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Elaborate
Doctors use Elaborate to send modern lab results that tell patients what the results mean and what to do next. Less admin time and panicked phone calls? That’s a brighter care journey for all. Elaborate is combating physician burnout by delivering doctor-approved, patient-friendly lab results. We reduce patient panic and give patients actionable insights about their health so they can take charge of their care, and reduce admin so doctors can focus on what they love most: caring for patients face-to-face.
To learn more about Elaborate, visit http://www.elaborate.com/
Contact:
Nicole Bocskocsky, Chief Executive Officer
919-906-7714
https://www.linkedin.com/in/nbocskocsky/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.